Ibio Inc Stock Beta

IBIO Stock  USD 2.64  0.19  7.76%   
Ibio Inc fundamentals help investors to digest information that contributes to Ibio's financial success or failures. It also enables traders to predict the movement of Ibio Stock. The fundamental analysis module provides a way to measure Ibio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ibio stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Ibio Inc Company Beta Analysis

Ibio's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current Ibio Beta

    
  -3.37  
Most of Ibio's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ibio Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Ibio Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Ibio is extremely important. It helps to project a fair market value of Ibio Stock properly, considering its historical fundamentals such as Beta. Since Ibio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ibio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ibio's interrelated accounts and indicators.
0.95-0.53-0.40.470.880.820.96-0.220.610.690.950.620.360.020.17-0.05-0.470.930.840.78
0.95-0.7-0.40.490.90.640.97-0.160.650.540.990.610.33-0.180.07-0.08-0.470.980.90.82
-0.53-0.70.14-0.14-0.59-0.03-0.720.24-0.710.09-0.7-0.320.220.390.190.170.39-0.62-0.83-0.79
-0.4-0.40.14-0.07-0.33-0.26-0.37-0.560.2-0.28-0.3-0.95-0.470.24-0.440.740.69-0.43-0.19-0.07
0.470.49-0.14-0.070.620.370.420.160.140.330.480.130.67-0.240.090.310.120.580.240.21
0.880.9-0.59-0.330.620.620.85-0.10.510.450.90.560.45-0.270.03-0.04-0.380.920.750.68
0.820.64-0.03-0.260.370.620.68-0.270.390.760.660.440.380.330.380.16-0.330.640.540.53
0.960.97-0.72-0.370.420.850.68-0.240.730.490.970.590.24-0.120.19-0.05-0.50.930.940.89
-0.22-0.160.24-0.560.16-0.1-0.27-0.24-0.64-0.14-0.230.340.63-0.320.24-0.320.03-0.02-0.43-0.52
0.610.65-0.710.20.140.510.390.73-0.640.150.690.02-0.290.05-0.050.31-0.180.530.830.89
0.690.540.09-0.280.330.450.760.49-0.140.150.530.370.420.43-0.08-0.05-0.160.550.310.22
0.950.99-0.7-0.30.480.90.660.97-0.230.690.530.530.29-0.160.050.01-0.420.970.920.86
0.620.61-0.32-0.950.130.560.440.590.340.020.370.530.42-0.240.4-0.69-0.790.620.440.33
0.360.330.22-0.470.670.450.380.240.63-0.290.420.290.42-0.20.370.020.050.49-0.06-0.14
0.02-0.180.390.24-0.24-0.270.33-0.12-0.320.050.43-0.16-0.24-0.2-0.160.190.38-0.24-0.15-0.16
0.170.070.19-0.440.090.030.380.190.24-0.05-0.080.050.40.37-0.160.03-0.350.110.060.14
-0.05-0.080.170.740.31-0.040.16-0.05-0.320.31-0.050.01-0.690.020.190.030.63-0.050.00.11
-0.47-0.470.390.690.12-0.38-0.33-0.50.03-0.18-0.16-0.42-0.790.050.38-0.350.63-0.4-0.5-0.47
0.930.98-0.62-0.430.580.920.640.93-0.020.530.550.970.620.49-0.240.11-0.05-0.40.820.74
0.840.9-0.83-0.190.240.750.540.94-0.430.830.310.920.44-0.06-0.150.060.0-0.50.820.98
0.780.82-0.79-0.070.210.680.530.89-0.520.890.220.860.33-0.14-0.160.140.11-0.470.740.98
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Ibio Inc has a Beta of -3.366. This is 491.4% lower than that of the Biotechnology sector and notably lower than that of the Health Care industry. The beta for all United States stocks is notably higher than that of the company.

Ibio Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ibio's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ibio could also be used in its relative valuation, which is a method of valuing Ibio by comparing valuation metrics of similar companies.
Ibio is currently under evaluation in beta category among its peers.

Ibio ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ibio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ibio's managers, analysts, and investors.
Environmental
Governance
Social
As returns on the market increase, returns on owning Ibio are expected to decrease by larger amounts. On the other hand, during market turmoil, Ibio is expected to outperform it.

Ibio Fundamentals

About Ibio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ibio Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ibio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ibio Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Ibio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ibio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will appreciate offsetting losses from the drop in the long position's value.

Moving against Ibio Stock

  0.67NKTX Nkarta IncPairCorr
  0.67CYRX CryoportPairCorr
  0.63MTEM Molecular TemplatesPairCorr
  0.61MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.56TPST Tempest TherapeuticsPairCorr
The ability to find closely correlated positions to Ibio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ibio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ibio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ibio Inc to buy it.
The correlation of Ibio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ibio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ibio Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ibio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ibio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ibio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ibio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ibio Inc Stock:
Check out Ibio Piotroski F Score and Ibio Altman Z Score analysis.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.03)
Revenue Per Share
0.059
Quarterly Revenue Growth
(0.88)
Return On Assets
(0.30)
Return On Equity
(0.84)
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.